In recent years, immunotherapeutic drugs, such as programmed cell death protein 1 (PD-1) or programmed cell death ligand 1 (PD-L1) inhibitors combined with chemotherapy, have made a breakthrough in BC treatment. The gene discussed is PDCD1; the disease is breast cancer.